the high bladder toxicity of the alkylating oxazaphosphorine anticancer drugs , cyclophosphamide and ifosfamide is effectively reduced by the concomitant administration of mesna ( sodium 2-mercaptoethane sulphonate ) .
C0010583
cyclophosphamide
C0020823
ifosfamide